Astodrimer Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT00370357SPL7013 Gel - Male Tolerance Study